Search

Artificial Intelligence and 3D Printing Shape the Future of Biomedical Science - Donanım Haber

Translated title. Original: Yapay Zekâ ve Üç Boyutlu Baskı Biyomedikal Biliminin Geleceğini Şekillendiriyor - Donanım Haber

Biomaterials, 3D printing, AI, and microfluidics are advancing biomedical science. The BİOMED 2026 symposium in Istanbul showcased interdisciplinary work, dozens of presentations, and international collaboration, with a focus on tissue repair, regenerative medicine, and translating research into clinical products; ongoing funding and IP support are needed to sustain progress.

OpenAI is Growing in Biotechnology: Acquires Orchestra Bio – NuvemMag

Translated title. Original: OpenAI, Biyoteknoloji Alanında Büyüyor: Orchestra Bio’yu Satın Aldı – NuvemMag

OpenAI acquires Orchestra Bio, a biotech AI software startup backed by investors like Andreessen Horowitz, aiming to run its tech on Rosalind Workbench to aid drug discovery research; the deal signals increasing AI lab penetration into pharma and reflects industry concerns about competition among labs.

Bio weapons: The increasing threat from AI and synthetic biology

Translated title. Original: Biovåpen: Den økende trusselen fra KI og syntetisk biologi

The document addresses the growing threat of bio weapons related to AI and synthetic biology, highlighting safety, ethics, and governance considerations.

Anthropic Bets on Life Sciences for Its IPO — Brief AI

Anthropic positions life sciences as central to its IPO strategy, detailing investments, partnerships (notably with Lilly), a new molecular biology lab, and the Claude Science product, while outlining ambitions to accelerate biotech research and compete with AI-focused peers. The narrative includes leadership perspectives and optimistic projections about AI's impact on medicine, alongside ongoing hiring and acquisitions to support the shift.

Biological computing - Wikipedia

The document describes biocomputers that use biological materials to perform computations, defining nanobiotechnology, and outlining three main biocomputer types—biochemical, biomechanical, and bioelectronic—along with network-based biocomputation and how inputs yield outputs via chemical, mechanical, or electrical signals.

SRTD Biotech from Jülich closes €31.5 million seed round - Business and Industry

Translated title. Original: SRTD Biotech aus Jülich schließt Seed-Runde über 31,5 Millionen Euro ab - Wirtschaft und Industrie

SRTD Biotech raised €31.5 million to advance its selective RNA therapies through preclinical development toward an IND filing. The company’s approach aims to release treatments in target cells, but the report provides no evidence yet of clinical or preclinical effectiveness.

Remote Lead Bioinformatics Scientist (Oncology) at Natera - Jobicy

Natera is hiring a Lead Bioinformatics Scientist in Oncology to lead analytical validation of NGS assays, develop real-world evidence studies, and build multi-source data pipelines. The role requires strong bioinformatics and statistics skills, cross-functional collaboration, and experience with regulated assay development.

The Best AI Health Innovators Have a Feel for People - TimmermanReport.com

AI’s impact on healthcare and drug development remains uncertain, and biology’s complexity and limited human data constrain predictions. Biotech founders Daphne Koller and Rosana Kapeller argue that experienced, collaborative teams will matter more than access to AI or data alone.

Phylo collaborates with Bayer on Biomni Lab AI agents for drug research – Unite.AI

Translated title. Original: Phylo werkt met Bayer samen aan AI-agents van Biomni Lab voor geneesmiddelenonderzoek – Unite.AI

Phylo announces a collaboration with Bayer to deploy Biomni Lab, an AI-enabled platform with agents that consolidate literature, omics data, and methods to accelerate drug research. The goal is to provide Bayer scientists with integrated workflows, maintain traceable context for sources, and enable broader, more ambitious inquiry while ensuring reliability and security for enterprise use.

The UK’s new AI Biosecurity Lab – SystemTek – Technology news and information

The UK announces the AI Biosecurity Lab (AIBL), the first dedicated AI biosecurity body, funded by the government (£100m) and private partners (up to £200m from OpenAI and Anthropic). AIBL will combine frontier AI with biological science to detect threats, accelerate vaccines and countermeasures, and strengthen global biosecurity resilience, working with public sector, academia, industry, and frontier AI firms. It will launch as a non-profit with partnerships across government agencies and life sciences.